|Last Price||Today's Change||52-Week Range||Trading Volume|
|110.00||0.97 (+0.89%)||96.43 - 143.45||1.9 million (Below Avg)|
Market data as of 3:59PM 10/09/15. Quotes are delayed by at least 15 min.
Vertex to Announce Third Quarter 2015 Financial Results on October 28
10/09/2015 9:00 AM ET
Supplemental New Drug Application for Use of KALYDECO® (ivacaftor) in People with Cystic Fibrosis Ages 2 and Older who have One of 23 Residual Function Mutations Accepted for Priority Review by U.S. FDA
10/07/2015 4:53 PM ET